SME Times is powered by   
Search News
Just in:   • Indo-Nepal trade: Let's Wait for the Dust to Settle   • India-US tariff stalemate likely to be resolved in 8-10 weeks: Chief Economic Advisor  • PM Modi-Trump phone call 'moment of bonhomie', says former senior Indian official  • India ready to take relationship with EU to next level: PM Modi to Ursula von der Leyen  • India's efforts to shape sustainable future across region lauded at East Asia Summit event 
Last updated: 27 Feb, 2025  

js.jpg India emerging as global biotech innovation hub: Jitendra Singh

js.jpg
   Top Stories
» India's contribution to global GDP growth to reach 9 pc by 2035: Govt official
» Centre to help ITIs become AI-driven training centres: FM Sitharaman
» Sensex, Nifty make strong gains amid positive cues after US Fed rate cut
» US Fed decision paves the way for RBI to go for more rate cuts: Analysts
» Piyush Goyal to embark on 2-day UAE visit today
IANS | 27 Feb, 2025

With 9,000 biotech startups, India has emerged as a global biotech innovation hub, said Dr. Jitendra Singh, Union Minister of State (Independent Charge) for Science and Technology, on Wednesday.

He said this while undertaking a review of research facilities at CSIR-Institute of Microbial Technology (CSIR-IMTECH), Chandigarh.

"The number of biotech startups in India has grown exponentially from just 50 in 2014 to nearly 9,000 today, solidifying India's position as a global hub for biotech innovation," Singh said.

He informed that India now ranks third in the Asia-Pacific region and 12th globally in bio-manufacturing, underscoring the increasing importance of research in microbial genetics, infectious diseases, fermentation technology, environmental microbiology, and bioinformatics.

At the Institute, he also inspected a microbe repository and took updates on ongoing projects.

"Microbial technology is a crucial pillar of biotechnology," the MoS said, while emphasising its growing significance in shaping the next generation industrial revolution.

Crediting Prime Minister Narendra Modi for the groundbreaking New BioE3 Policy, which places a renewed focus on biomanufacturing and bio foundries, Singh underscored India's rapid progress in the biotech sector.

“India’s bioeconomy has witnessed an extraordinary surge from $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030,” he added.

Further, the Minister connected virtually with CSIR-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur, to inaugurate several new facilities and participate in critical scientific discussions.

He joined the EMBO Workshop on High Elevation Plant Adaptation in a Changing Climate (HEPACC) and the Industry, Farmer & Academia (IFA) Meet, inaugurated a New Tulip Garden at Palampur in Himachal Pradesh, and launched products developed by agri-startups that have been supported by the institute, fostering innovation in the agricultural sector.

"By integrating scientific research, industry collaboration, and government policies, the rich biodiversity of Himalayan states can be harnessed for economic prosperity," Singh said. He added that it will also benefit farmers and advance India’s scientific ecosystem.

 
Print the Page
Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹84.00
₹82.25
UK Pound
₹104.65
₹108.10
Euro
₹92.50
₹89.35
Japanese Yen ₹56.10 ₹54.40
As on 25 Jul, 2025
  Daily Poll
Who do you think will benefit more from the India - UK FTA in the long run?
 Indian businesses & consumers.
 UK businesses & consumers.
 Both will gain equally.
 The impact will be negligible for both.
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter